Filing Flows

Filing Flows › Carlsmed (CARL) › Who owns the stock

Who owns Carlsmed (CARL) stock

69 funds reported Carlsmed (CARL) shares in their latest 13F filings, worth $74.6M in all. The largest holder is Jupiter Topco LLC ($13.0M). Last quarter 46 funds added to their stakes and 23 cut them.

Largest holders of CARL (13F)Largest holders of CARL (13F)Jupiter Topco LLC$13.0MJanus Henderson Group$11.1MParkman Healthcare Partners LLC$6.2MBlackRock$5.5MKCM Capital$4.6MVanguard Group$4.4MPier Capital, LLC$3.9MMillennium Management LLC$3.1MPalumbo Wealth Management LLC$2.8MVanguard Capital Management LLC$2.5M

Largest holders (13F)

FundSharesValueChangeQuarter
Jupiter Topco LLC1,251,616$13.0Mbase2026-06-30
Janus Henderson Group1,227,452$11.1Mincrease2026-03-31
Parkman Healthcare Partners LLC597,318$6.2Mincrease2026-06-30
BlackRock532,593$5.5Mincrease2026-06-30
KCM Capital440,000$4.6Mincrease2026-06-30
Vanguard Group360,082$4.4Mincrease2025-12-31
Pier Capital, LLC373,677$3.9Mnew2026-06-30
Millennium Management LLC295,907$3.1Mnew2026-06-30
Palumbo Wealth Management LLC267,298$2.8Mnew2026-06-30
Vanguard Capital Management LLC238,727$2.5Mdecrease2026-06-30
Schonfeld Strategic Advisors LLC224,804$2.3Mdecrease2026-06-30
Geode Capital Management, LLC204,655$2.1Mincrease2026-06-30
Russell Investments Group139,142$1.4Mdecrease2026-06-30
State Street133,083$1.4Mincrease2026-06-30
Citadel Advisors LLC101,726$1.1Mincrease2026-06-30

Carlsmed's latest quarter

Carlsmed, Q2 2026: revenue $18.9M (+57% year over year), operating margin -58.3%, net loss $10.5M, operating cash flow −$7.4M. The chart follows the revenue to costs, profit and cash.

Questions

Who owns the most CARL stock?

By the latest 13F filings: Jupiter Topco LLC ($13.0M); Janus Henderson Group ($11.1M); Parkman Healthcare Partners LLC ($6.2M); BlackRock ($5.5M); KCM Capital ($4.6M).

What is the short interest in CARL?

1,094,864 shares were sold short at the 2026-10-15 settlement, 3.88% of the float.

Open the interactive view →

Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.